Furthermore, among participants with T2D treated with insulin, 100% (n=2) in HM, 83.3% (n=5) in VM, and 62.5% (n=5) in iPM stopped insulin at 12 weeks. This evidence concerns the gene INS and type 2 diabetes mellitus.